📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. (2022)

First Author: Van Doorn CLR

Attributed to: The Role of Complement Component C1Q in Tuberculosis and Diabetes Co-morbidity funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104173

PubMed Identifier: 35841871

Publication URI: http://europepmc.org/abstract/MED/35841871

Type: Journal Article/Review

Volume: 82

Parent Publication: EBioMedicine

ISSN: 2352-3964